Enzymotec Ltd
ENZY
ENZY was delisted on the 10th of January, 2018.
30 hedge funds and large institutions have $88M invested in Enzymotec Ltd in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 7 closing their positions.
6% more capital inflows, than outflows
Capital inflows: $2.77M | Capital outflows: $2.62M
0% more funds holding
Funds holding: 30 → 30 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
0% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 8
43.59% less ownership
Funds ownership: 43.59% → 0% (-44%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Janus Henderson Investors US
Denver,
Colorado
|
+$1.21M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$441K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$215K |
| 4 |
Algert Global
San Francisco,
California
|
+$183K |
| 5 |
IA
Icon Advisers
Greenwood Village,
Colorado
|
+$146K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$871K |
| 2 |
Renaissance Technologies
New York
|
-$320K |
| 3 |
Goldman Sachs
New York
|
-$316K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$305K |
| 5 |
TM
Tiger Management
New York
|
-$172K |
ENZY Hedge Fund Activity: Q1 2016 in Review
30 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Enzymotec Ltd (ENZY) for Q1 2016, worth a combined $88M — down 7.6% from $95.2M a quarter earlier.
Fund positioning in ENZY was balanced in Q1 2016: 7 funds opened new positions, 7 closed out, 8 added to existing stakes and 8 trimmed.
The largest buyer was Janus Henderson Investors US, opening a new position worth an estimated $1.21M. The largest seller was Bank of America, cutting an estimated $871K.
- 30 institutional investors held Enzymotec Ltd (ENZY) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $88M of Enzymotec Ltd stock for Q1 2016, down 7.6% quarter-over-quarter.
- 7 funds opened new Enzymotec Ltd positions in Q1 2016 and 7 closed out, a net change of 0 holders.
- The largest Enzymotec Ltd buyer in Q1 2016 was Janus Henderson Investors US, an estimated $1.21M added.
- The largest Enzymotec Ltd seller in Q1 2016 was Bank of America, an estimated $871K sold.
Based on aggregated 13F filings for Q1 2016.